Loading…
Reported covered position: Chief of Staff - Office of the Vice Chair, Senate Republican Conference; Chief of Staff - Office of Sen. Roy Blunt; Chief of Staff - Office of Sen. Sam Brownback
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Consolidated Appropriations Act, 2021
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
Prescription Drug STAR Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2020 · fourth_quarter · Q4
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Source: Senate LDA
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Shop Rx Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Shop Rx Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
The Dr. Joseph Costa Honoring Essential Americans Risking Their Safety Act of 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
FAST Generics Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosimilar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 H.R. 133, Consolidated Appropriations Act, 2021
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Drug Pricing Reduction Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Patient Access to ESRD New Innovative Devices Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Patient Access to ESRD New Innovative Devices Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Lower Costs, More Cures Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Lower Costs, More Cures Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Lower Costs, More Cures Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act
Bringing Enhanced Treatments and Therapies to ESRD Recipients (BETTER) Kidney Care Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Creating Transparency to Have Drug Rebates Unlocked (C–THRU) Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits.
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits.
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
ACE Kids Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019
ACE Kids Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
Health Insurance Tax Relief Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019
Protecting Consumer Access to Generic Drugs Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Protecting Consumer Access to Generic Drugs Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
John S. McCain Opioid Addiction Prevention Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Further Consolidated Appropriations Act, 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Further Consolidated Appropriations Act, 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
2020 · third_quarter · Q3
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to the competitive nature of the pharmacy benefit management industry. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 S. 4317, The Safe to Work Act
Issues related to implementation and changes to the Affordable Care Act.
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 H.R. 7659, The Ensuring Parity for MA in Audio-only Telehealth Act of 2020 H.R. 8245/S. 4574, The Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2020 · second_quarter · Q2
Issues related to medication adherence, drug price transparency, prescription drug abuse, and COVID testing. S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid (including increasing Medicaid funding to states), and the ESRD program. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to employer, small group and individual insurance markets, including surprise billing and increasing COBRA subsidies for individuals to maintain coverage. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 H.R. 6800, The Health and Economic Recovery Omnibus Emergency Solutions Act of 2020 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2020 · first_quarter · Q1
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinants of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 748, The Coronavirus Aid, Relief, and Economic Security Act H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovative Devices Act of 2019 S. 3013, The Encouraging Innovative Benefit Design to Lower Costs for Seniors Act of 2019 S. 3129, The Lower Costs, More Cures Act of 2019
Issues related to barriers to generic drug and biosimilar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · fourth_quarter · Q4
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · third_quarter · Q3
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · second_quarter · Q2
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · first_quarter · Q1
Issues related to implementation and changes to the Affordable Care Act.
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. S. 657, The Drug Price Transparency Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Treasury, Dept of, White House Office
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of